Phase i study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy

British Journal of Radiology

Volumn 89, Issue 1058, 2016, Pages

  Zhao, Hanxi ^a   Zhu, Wanqi ^a   Jia, Li ^b   Sun, Xiaorong ^a,c   Chen, Guanxuan ^c   Zhao, Xianguang ^a   Li, Xiaolin ^a   Meng, Xiangjiao ^a   Kong, Lingling ^a   Xing, Ligang ^a,c   Yu, Jinming ^a,c  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b Jinan Fourth People's Hospital   (China)

^c Shandong's Key Laboratory of Radiation Oncology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; ANTIOXIDANT; CATECHIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MASTECTOMY; PHASE 1 CLINICAL TRIAL; RADIATION DERMATITIS; SKIN REDNESS; SYMPTOMATOLOGY; ADJUVANT RADIOTHERAPY; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CLINICAL TRIAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIODERMATITIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; CONFERENCE PAPER; RADIATION HAZARD; RECOMMENDED DRUG DOSE;

ADMINISTRATION, TOPICAL; ADULT; ANTIOXIDANTS; BREAST NEOPLASMS; CATECHIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; RADIODERMATITIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84957928314     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20150665     Document Type: Article

References (40)

1. Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D, et al. Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat 2007; 106: 143-50. doi: 10.1007/s10549-006-9480-9
2. Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensitymodulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26: 2085-92. doi: 10.1200/JCO.2007.15.2488
3. Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K, et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol 2010; 11: 258-65. doi: 10.1016/S1470-2045(10)70013-9
4. Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, et al. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 2012; 83: 1089-94. doi: 10.1016/j.ijrobp.2011.09.021
5. Chan RJ, Larsen E, Chan P. Re-examining the evidence in radiation dermatitis management literature: an overview and a critical appraisal of systematic reviews. Int J Radiat Oncol Biol Phys 2012; 84: e357-62. doi: 10.1016/j. ijrobp.2012.05.009
6. Fisher J, Scott C, Stevens R, Marconi B, Champion L, Freedman GM, et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000; 48: 1307-10. doi: 10.1016/S0360-3016(00) 00782-3
7. Graham PH, Plant N, Graham JL, Browne L, Borg M, Capp A, et al. A paired, doubleblind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01. Int J Radiat Oncol Biol Phys 2013; 86: 45-50. doi: 10.1016/j.ijrobp.2012.12.009
8. Yoshioka H, Kurosaki H, Yoshinaga K, Saito K, Yoshioka H. Beta ray-induced scission of DNA in tritiated water and protection by a green tea percolate and (-)-epigallocatechin gallate. Biosci Biotechnol Biochem 1997; 61: 1560-3. doi: 10.1271/bbb.61.1560
9. Hu Y, Cao JJ, Liu P, Guo DH, Wang YP, Yin J, et al. Protective role of tea polyphenols in combination against radiation-induced haematopoietic and biochemical alterations in mice. Phytother Res 2011; 25: 1761-9. doi: 10.1002/ptr.3483
10. Peng Z, Xu ZW, Wen WS, Wang RS. Tea polyphenols protect against irradiationinduced injury in submandibular glands' cells: a preliminary study. Arch Oral Biol 2011; 56: 738-43. doi: 10.1016/j. archoralbio.2010.12.009
11. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 2001; 44: 425-32. doi: 10.1067/mjd.2001.112919
12. Kim HK, Choi SY, Chang HK, Baek SY, Chung JO, Rha CS, et al. Human skin safety test of green tea cell extracts in condition of allergic contact dermatitis. Toxicol Res 2012; 28: 113-16. doi: 10.5487/TR.2012.28.2.113
13. Gez E, Assaf N, Bar-Deroma R, Rosenblatt E, Kuten A. Postmastectomy electron-beam chest-wall irradiation in women with breast cancer. Int J Radiat Oncol Biol Phys 2004; 60: 1190-4. doi: 10.1016/j.ijrobp.2004.05.036
14. Lopez E, Nuñez MI, Guerrero MR, del Moral R, de Dios Luna J, del Mar Rodrguez M, et al. Breast cancer acute radiotherapy morbidity evaluated by different scoring systems. Breast Cancer Res Treat 2002; 73: 127-34. doi: 10.1023/A:1015296607061
15. Neben-Wittich MA, Atherton PJ, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, et al. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). Int J Radiat Oncol Biol Phys 2011; 81: 397-402. doi: 10.1016/j.ijrobp.2010.05.065
16. Elliott EA, Wright JR, Swann RS, Nguyen-Tân F, Takita C, Bucci MK, et al; Radiation Therapy Oncology Group Trial 99-13. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol 2006; 24: 2092-7. doi: 10.1200/JCO.2005.04.9148
17. Rollmann DC, Novotny PJ, Petersen IA, Garces YI, Bauer HJ, Yan ES, et al. Doubleblind, placebo-controlled pilot study of processed ultra emu oil versus placebo in the prevention of radiation dermatitis. Int J Radiat Oncol Biol Phys 2015; 92: 650-8. doi: 10.1016/j.ijrobp.2015.02.028
18. Hindley A, Zain Z, Wood L, Whitehead A, Sanneh A, Barber D, et al. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys 2014; 90: 748-55. doi: 10.1016/j.ijrobp.2014.06.033
19. Lewis L, Carson S, Bydder S, Athifa M, Williams AM, Bremner A. Evaluating the effects of aluminum-containing and nonaluminum containing deodorants on axillary skin toxicity during radiation therapy for breast cancer: a 3-armed randomized controlled trial. Int J Radiat Oncol Biol Phys 2014; 90: 765-71. doi: 10.1016/j.ijrobp.2014.06.054
20. Chan RJ, Mann J, Tripcony L, Keller J, Cheuk R, Blades R, et al. Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial. Int J Radiat Oncol Biol Phys 2014; 90: 756-64. doi: 10.1016/j.ijrobp.2014.06.034
21. Herst PM, Bennett NC, Sutherland AE, Peszynski RI, Paterson DB, Jasperse ML. Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother Oncol 2014; 110: 137-43. doi: 10.1016/j. radonc.2014.01.005
22. Ulff E, Maroti M, Serup J, Falkmer U. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams. Radiother Oncol 2013; 108: 287-92. doi: 10.1016/j.radonc.2013.05.033
23. Sharp L, Finnilä K, Johansson H, Abrahamsson M, Hatschek T, Bergenmar M. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions-results from a randomised blinded trial. Eur J Oncol Nurs 2013; 17: 429-35. doi: 10.1016/j.ejon.2012.11.003
24. Hemati S, Asnaashari O, Sarvizadeh M, Motlagh BN, Akbari M, Tajvidi M, et al. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer 2012; 20: 1613-18. doi: 10.1007/s00520-011-1250-5
25. Kirova YM, Fromantin I, De Rycke Y, Fourquet A, Morvan E, Padiglione S, et al. Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. Radiother Oncol 2011; 100: 205-9. doi: 10.1016/j.radonc.2011.05.014
26. Jensen JM, Gau T, Schultze J, Lemmnitz G, Fölster-Holst R, May T, et al. Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial. Strahlenther Onkol 2011; 187: 378-84. doi: 10.1007/s00066-011-2224-8
27. Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys 2011; 79: 1460-6. doi: 10.1016/j. ijrobp.2010.01.031
28. Gosselin TK, Schneider SM, Plambeck MA, Rowe K. A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy. Oncol Nurs Forum 2010; 37: 619-26. doi: 10.1188/10. ONF.619-626
29. Pajonk F, Riedisser A, Henke M, McBride WH, Fiebich B. The effects of tea extracts on proinflammatory signaling. BMC Med 2006; 4: 28 doi: 10.1186/1741-7015-4-28
30. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks JA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003; 9: 3312-19.
31. Zhao H, Zhu W, Xie P, Li H, Zhang X, Sun X, et al. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer. Radiother Oncol 2014; 110: 132-6. doi: 10.1016/j. radonc.2013.10.014
32. Richi B, Kale RK, Tiku AB. Radiomodulatory effects of green tea catechin EGCG on pBR322 plasmid DNA and murine splenocytes against gamma-radiation induced damage. Mutat Res 2012; 747: 62-70. doi: 10.1016/j.mrgentox.2012.04.002
33. Mitrica R, Dumitru I, Ruta LL, Ofiteru AM, Farcasanu IC. The dual action of epigallocatechin gallate (EGCG), the main constituent of green tea, against the deleterious effects of visible light and singlet oxygen-generating conditions as seen in yeast cells. Molecules 2012; 17: 10355-69. doi: 10.3390/molecules170910355
34. Nam S, Smith DM, Dou QP. Ester bondcontaining tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 2001; 276: 13322-30. doi: 10.1074/jbc. M004209200
35. Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001; 60: 528-33.
36. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK. Suppression of lipopolysaccharideinduced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol 2000; 59: 357-67. doi: 10.1016/S0006-2952(99)00335-4
37. Xu JZ, Yeung SY, Chang Q, Huang Y, Chen ZY. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br J Nutr 2004; 91: 873-81. doi: 10.1079/BJN20041132
38. Ikeda I, Kobayashi M, Hamada T, Tsuda K, Goto H, Imaizumi K, et al. Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J Agric Food Chem 2003; 51: 7303-7. doi: 10.1021/jf034728l
39. Lee SM, Kim CW, Kim JK, Shin HJ, Baik JH. GCG-rich tea catechins are effective in lowering cholesterol and triglyceride concentrations in hyperlipidemic rats. Lipids 2008; 43: 419-29. doi: 10.1007/s11745-008-3167-4
40. Fangueiro JF, Parra A, Silva AM, Egea MA, Souto EB, Garcia ML, et al. Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate. Int J Pharm 2014; 475: 181-90. doi: 10.1016/j.ijpharm.2014.08.053